Justin Stebbing
Justin Stebbing is a world-renowned cancer specialist, widely regarded as one of the most talented people in his field. Justin is an NIHR Research Professor of Cancer Medicine and Oncology at Imperial College London specializing in immunotherapy for breast, gastrointestinal, and lung cancers. In addition to his global groundbreaking contributions to cancer research, he has extensive work on biosimilars and cheaper versions of expensive biologic drugs designed to democratize access to these around the world in 2020 at the start of the Covid pandemic. Justin has published over 550 peer-reviewed papers in journals such as The Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as presenting data at international conferences.
Justin Stebbing Professional Experience / Academic History
Professional Experience
-
NIHR Research Translational Professor
-
Professor of Cancer Medicine and Medical Oncology
-
Medical Research Council Clinical Training Fellow
Academic History
-
Medicine
-
BM BCh MA FRCP FRCPath PhD MD, Medicine
AWARDS AND RECOGNITION
Elected Member, The American Society for Clinical Investigation
In cancer, one of his most cited papers includes the discovery of the role of the oncogene LMTK3 across malignancies.
He is also cited for the network of microRNAs induced by the estrogen receptor, and extensive work on HIV and AIDS cancers.
His laboratory work is concentrated on druggable target discovery, biomarkers of response and the role of immunotherapy.
MEDIA
Justin has appeared as a guest on Real Vision.
AFFILIATIONS AND INVOLVEMENT